Equity
Common Stock
Amgen Common Stock increased by 0.5% to $34.02B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $33.53B to $34.02B. Over 5 years (FY 2020 to FY 2025), Common Stock shows relatively stable performance with a 1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Changes are typically driven by share issuances or buybacks, reflecting capital allocation decisions.
Detailed definition
This represents the par value of the common shares issued by the company. It is a component of shareholders' equity and...
Peer comparison
A standard equity line item found on the balance sheets of all publicly traded companies.
Metric ID:
common_stockHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.88B | $31.99B | $32.10B | $31.25B | $31.34B | $32.37B | $32.51B | $32.54B | $32.60B | $32.75B | $33.07B | $33.08B | $33.20B | $33.39B | $33.53B | $33.58B | $33.68B | $33.84B | $34.02B |
| QoQ Change | — | +0.4% | +0.3% | -2.6% | +0.3% | +3.3% | +0.4% | +0.1% | +0.2% | +0.5% | +1.0% | +0.0% | +0.4% | +0.6% | +0.4% | +0.1% | +0.3% | +0.5% | +0.5% |
| YoY Change | — | — | — | — | -1.7% | +1.2% | +1.3% | +4.1% | +4.0% | +1.2% | +1.7% | +1.7% | +1.8% | +2.0% | +1.4% | +1.5% | +1.4% | +1.3% | +1.5% |
Range$31.25B – $34.02B
CAGR+1.5%
Avg YoY Growth+1.6%
Median YoY Growth+1.5%
Current Streak15 quarters growth
Common Stock at Other Companies
Frequently Asked Questions
- What is Amgen's common stock?
- Amgen (AMGN) reported common stock of $34.02B in Q4 2025.
- How has Amgen's common stock changed year-over-year?
- Amgen's common stock increased by 1.5% year-over-year, from $33.53B to $34.02B.
- What is the long-term trend for Amgen's common stock?
- Over 5 years (2020 to 2025), Amgen's common stock has grown at a 1.4% compound annual growth rate (CAGR), from $31.80B to $34.02B.
- What does common stock mean?
- The accounting value of the company's issued common shares.